Tiziana Life Sciences Ltd (NASDAQ:TLSA) has unveiled new neuroimaging data which shows its investigational drug intranasal foralumab improved White Matter...…
Tiziana Life Sciences Ltd (NASDAQ:TLSA) has unveiled additional positive results from its Expanded Access Program for patients with non-active secondary...…
^NEW YORK, May 26, 2023 (GLOBE NEWSWIRE) -- Tiziana Life Sciences
Ltd. (Nasdaq: TLSA
(https://www.globenewswire.com/Tracker?data=Da7y274MU3yOxM9bXl5wDaSpK_MuVZebAm5d
_aX_enJfFuDXy3eVaNOXgEiSEcFrK4-
k7swqAuOfbT7mCmohxonIugzMpEs1nIAqhkjJ4Ux9zDwiEFRXYY7BisXOfu9Z)) (?Tiziana" oder
das ?Unternehmen"),…